27 results on '"Haroun, R"'
Search Results
2. Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for The Treatment of Heart Failure In Argentina
3. Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Chile
4. Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland
5. The Cost-Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure with Reduced Ejection Fraction: The Use of Model Calibration To Improve Generalisability To A UK CHF Population
6. Cost-Effectiveness of Sacubitril/ Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in The Czech Republic: Analysis Based on Patient Characteristics From Randomized Clinical Trial and Local Registries
7. The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in England and Scotland: Applying Real-World Evidence to Enhance Generalisability to A UK Population
8. Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy
9. Cost-Effectiveness of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction in Sweden
10. The Cost-Effectiveness Of Treatment For Chronic Heart Failure: A Systematic Review
11. A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction
12. Systematic Review Of The Societal Cost And Economic Burden Associated With Chronic Heart Failure
13. PCV23 - Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for The Treatment of Heart Failure In Argentina
14. PCV150 - Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Mexico
15. PCV153 - Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Chile
16. PCV106 - Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland
17. PCV108 - The Cost-Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure with Reduced Ejection Fraction: The Use of Model Calibration To Improve Generalisability To A UK CHF Population
18. PCV104 - The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in England and Scotland: Applying Real-World Evidence to Enhance Generalisability to A UK Population
19. PCV91 - Cost-Effectiveness of Sacubitril/ Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in The Czech Republic: Analysis Based on Patient Characteristics From Randomized Clinical Trial and Local Registries
20. PCV80 - Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy
21. PCV82 - Cost-Effectiveness of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction in Sweden
22. PCV118 - A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction
23. PCV101 - The Cost-Effectiveness Of Treatment For Chronic Heart Failure: A Systematic Review
24. PCV57 - Systematic Review Of The Societal Cost And Economic Burden Associated With Chronic Heart Failure
25. PCV101 The Cost-Effectiveness Of Treatment For Chronic Heart Failure: A Systematic Review
26. PCV118 A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction
27. PCV57 Systematic Review Of The Societal Cost And Economic Burden Associated With Chronic Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.